Cabaletta Bio, Inc. · NASDAQ:CABA
The Vanguard Group's stake in Cabaletta Bio, Inc. fell to 3.83% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group's stake in Cabaletta Bio, Inc. fell to 3.83%, 3,450,727 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 3.83%
- Shares
- 3,450,727
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 3.83% | 3,450,727 |
Source
Related
- Cabaletta Bio, Inc.
- The Vanguard Group
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026